“Registry-based research is not a plaything for academics but a bridge between science and practice”
Few, but severe strokes in hospitalised COVID-19 patientsRemarkable: patients did not have a greater risk of cardiovascular disease beforehand
"Fast results of COVID-19 research thanks to close cooperation within the DCVA"
Severe heart failure increases mortality risk in COVID-19 patients
Call for registry-based research
Additional study into COVID-19-care by general practitioner
The study, which is an extension of the DCVA COVID@HEART study, is focused on people who get COVID-19 but are not hospitalized.
What are the plans of the Dutch CardioVascular Alliance in 2021?
First FIRST-fund investment in potential medicine for stroke
Two years in alliance
Two years ago, the Dutch CardioVascular Alliance was officially launched. Let's take a trip down memory lane, and look back at some of the highlights.
Young@heart played an active part in record breaking ESC
In close collaboration with the ESC Scientists and Clinicians of Tomorrow,Young@Heart designed hundreds of cutting edge scientific sessions for this year's ESC congress, which turned out to become a record-breaking event.
Meet three new partners
Earlier this year, the DCVA gained three valuable partners. Learn what these three parties stand for, how they are valuable to the DCVA, and how the DCVA is valuable to them.
Start of the DCVA Leadership Program 2020
The first edition of the DCVA Leadership Program officially started. During three days of training and social interaction Margreet van Rixtel trained the fifteen participants in taking their first steps of becoming leaders who are able to solve complex current healthcare related problems.
New implementation consortium CUSTOM-AF
Preventing cerebral infarctions caused by atrial fibrillation. That is the main goal of the implementation consortium CUSTOM-AF.
DCVA COVID-19 update
Are COVID-19 patients at increased risk to develop ischemic stroke and what are the first results of CAPACITY? In this update, we present the new COVID-19 project STROCORONA and the first results of CAPACITY.
Meet the partnersA double interview
In this sixth and final edition of Meet the partners, we interview leaders of two of these partners, namely Floris Italianer (left), CEO of the Dutch Heart Foundation and prof. dr. Arno Hoes (right), dean of the Faculty of Medicine of the UMC Utrecht and formal prepresentative of the NFU.
4th Translational Cardiovascular Research Meeting
Although the setup was a little different than that of the former three editions, the congress was again well received.
Join Y@H or become a mentor
To strengthen our cardiovascular talent community, we invite PhD students and post-docs to actively participate in Young@Heart activities.
Help us review the EU blueprint
The ESC and the EHN have launched a blueprint for EU action against cardiovascular disease. We invite researchers and leaders in the field to read the this document and share your insights.
Hospitals sought for Valsartan study
Can Valsartan prevent serious accumulation of fluid in the lungs in COVID-19? To answer this question, the Dutch Cardiovascular Alliance started the Praetorian COVID study. Initiators and research leaders Niels van Royen and Roland van Kimmenade (Radboudumc) are urging colleagues from other hospitals to participate.
COVID-19 research: avoid duplicationRegister your COVID studies
Avoid duplication, combine efforts, maximise results, register your COVID-studies now